Sturm I - Search Results

1

Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.

Güner D, Sturm I, Hemmati P, Hermann S, Hauptmann S, Wurm R, Budach V, Dörken B, Lorenz M, Daniel PT. Güner D, et al. Among authors: sturm i. Int J Cancer. 2003 Feb 10;103(4):445-54. doi: 10.1002/ijc.10850. Int J Cancer. 2003. PMID: 12478659

2

Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.

Schelwies K, Sturm I, Grabowski P, Scherübl H, Schindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dörken B, Daniel PT. Schelwies K, et al. Among authors: sturm i. Int J Cancer. 2002 Jun 1;99(4):589-96. doi: 10.1002/ijc.10380. Int J Cancer. 2002. PMID: 11992551

3

Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.

Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S, Wust P, Riess H, Schlag PM, Dörken B, Daniel PT. Rau B, et al. Among authors: sturm i. J Clin Oncol. 2003 Sep 15;21(18):3391-401. doi: 10.1200/JCO.2003.07.077. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885834

4

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.

Sturm I, Bosanquet AG, Hummel M, Dörken B, Daniel PT. Sturm I, et al. BMC Cancer. 2005 Aug 18;5:105. doi: 10.1186/1471-2407-5-105. BMC Cancer. 2005. PMID: 16109171 Free PMC article.

5

Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.

Sturm I, Bosanquet AG, Radetzki S, Hummel M, Dörken B, Daniel PT. Sturm I, et al. Int J Cancer. 2006 May 1;118(9):2329-36. doi: 10.1002/ijc.21535. Int J Cancer. 2006. PMID: 16331630

6

Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.

Grabowski P, Sturm I, Schelwies K, Maaser K, Buhr HJ, Dörken B, Zeitz M, Daniel PT, Scherübl H. Grabowski P, et al. Among authors: sturm i. Int J Colorectal Dis. 2006 Apr;21(3):221-30. doi: 10.1007/s00384-005-0779-5. Epub 2005 Jun 14. Int J Colorectal Dis. 2006. PMID: 16485142

7

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy.

Sturm I, Rau B, Schlag PM, Wust P, Hildebrandt B, Riess H, Hauptmann S, Dörken B, Daniel PT. Sturm I, et al. BMC Cancer. 2006 May 10;6:124. doi: 10.1186/1471-2407-6-124. BMC Cancer. 2006. PMID: 16686938 Free PMC article.

8

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.

Sturm I, Köhne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B, Daniel PT. Sturm I, et al. J Clin Oncol. 1999 May;17(5):1364-74. doi: 10.1200/JCO.1999.17.5.1364. J Clin Oncol. 1999. PMID: 10334520

9

Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene.

Sturm I, Papadopoulos S, Hillebrand T, Benter T, Lück HJ, Wolff G, Dörken B, Daniel PT. Sturm I, et al. Int J Cancer. 2000 Aug 15;87(4):517-21. doi: 10.1002/1097-0215(20000815)87:4<517::aid-ijc9>3.0.co;2-b. Int J Cancer. 2000. PMID: 10918191

10

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.

Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, Hauptmann S, Dörken B, Daniel PT. Sturm I, et al. J Clin Oncol. 2001 Apr 15;19(8):2272-81. doi: 10.1200/JCO.2001.19.8.2272. J Clin Oncol. 2001. PMID: 11304781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters